Cancer Epidemiology, Biomarkers & Prevention

Using Polygenic Risk Scores to Refine Risk and Outcomes in High-grade Serous Ovarian Cancer in Australia

By Rachel Delahunty, S. Sandun M. Silva, Ahwan Pandey, Paul Andrew James

Case-control study of 1,097 peopleBiomarkers

The paper

Rachel Delahunty, S. Sandun M. Silva, Ahwan Pandey, Paul Andrew James

Barwon Health; The Royal Melbourne Hospital

Cancer Epidemiology, Biomarkers & Prevention, 6 Aug 2026

doi.org/10.1158/1055-9965.epi-25-1882 PubMed 42560169

Research Square7 Oct 2026
Inherited gene variants linked to breast cancer risk in UAE
medRxiv4 Oct 2026
Genetic scores add more predictive power at lower clinical risk
medRxiv9 Oct 2026
Polygenic risk links to disease burden and hospital use in Taiwan
medRxiv8 Oct 2026
Combining DNA and protein scores improves prediction in people